← Leaderboards
Erik Wambre
Benaroya Research Inst At Virginia Mason
$5,685,770
Attributed
$7,368,960
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,368,960 · 5
By mechanism
R01$4,371,529 · 2
U19$2,997,431 · 3
Top collaborators
- Jane Hoyt Buckner3 shared
- Laura Chow3 shared
- Peter S Linsley3 shared
Most similar at Benaroya Research Inst At Virginia Mason
Same institution · by research overlap
- William W. Kwok$17,461,298
- Peter S Linsley$7,467,441
- Stephen Reginald Durham$522,532
- Stephen James Till$522,532
- Matthew C. Altman$2,143,970
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsT-LymphocyteResponsePhenotypeT Cell ResponseBiological MarkersLeadHeterogeneityHypersensitivityAllergensSamplingImmuneRegulatory T-LymphocyteAntigensImmune ResponseFundingFood HypersensitivityImmunotherapyImmune ToleranceStainsDesensitizationCd4 Positive T LymphocytesDesignAllergic
Grant awards (16)
HIPC U19 Adaptive Immunophenotyping Core$406,158
U19 · FY2025 · AI · contact PI
HIPC U19 Adaptive Immunophenotyping Core$212,638
U19 · FY2024 · AI · contact PI
Allergen T cell epitopes and phenotypes during peanut immunotherapy$388,682
U19 · FY2022 · AI · contact PI
HIPC U19 Adaptive Immunophenotyping Core$326,266
U19 · FY2022 · AI · contact PI
Allergen T cell epitopes and phenotypes during peanut immunotherapy$539,802
U19 · FY2021 · AI · contact PI
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$423,377
R01 · FY2021 · CA
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$946,097
R01 · FY2020 · CA
Allergen T cell epitopes and phenotypes during peanut immunotherapy$324,621
U19 · FY2020 · AI · contact PI
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$874,780
R01 · FY2019 · CA
Allergen T cell epitopes and phenotypes during peanut immunotherapy$386,424
U19 · FY2019 · AI · contact PI
Induction and signature of pathogenic T cells in allergy$425,455
R01 · FY2018 · AI · contact PI
Allergen T cell epitopes and phenotypes during peanut immunotherapy$412,840
U19 · FY2018 · AI · contact PI
Induction and signature of pathogenic T cells in allergy$425,455
R01 · FY2017 · AI · contact PI
Induction and signature of pathogenic T cells in allergy$425,455
R01 · FY2016 · AI · contact PI
Induction and signature of pathogenic T cells in allergy$425,455
R01 · FY2015 · AI · contact PI
Induction and signature of pathogenic T cells in allergy$425,455
R01 · FY2014 · AI · contact PI